Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Uday K Baliga"'
Autor:
In-Hong Kang, Uday K. Baliga, Shilpak Chatterjee, Paramita Chakraborty, Seungho Choi, Nathan Buchweitz, Hong Li, Yongren Wu, Hai Yao, Shikhar Mehrotra, Meenal Mehrotra
Publikováno v:
iScience, Vol 25, Iss 9, Pp 104818- (2022)
Summary: Osteogenesis imperfecta (OI) is characterized by repeated bone fractures. Recent studies have shown that T lymphocytes and regulatory T cells (Tregs) regulate the functions of osteoclasts and osteoblasts, thus playing a role in bone turnover
Externí odkaz:
https://doaj.org/article/a0148aeb816341b9a09a8f987bf153a9
Autor:
David A. Dean, Uday K Baliga
Publikováno v:
Exp Biol Med (Maywood)
Delivery of genetic material to tissues in vivo is an important technique used in research settings and is the foundation upon which clinical gene therapy is built. The lung is a prime target for gene delivery due to a host of genetic, acquired, and
Autor:
Uday K Baliga, Shikhar Mehrotra, Amanda C. LaRue, Meenal Mehrotra, Hai Yao, Yongren Wu, In-Hong Kang
Publikováno v:
SSRN Electronic Journal.
Currently, there is no cure for Osteogenesis imperfecta (OI) - a debilitating pediatric skeletal dysplasia. Herein we show that hematopoietic stem cell (HSC) therapy holds promise in treating OI. Using single cell HSC transplantation in lethally irra
Autor:
Paramita Chakraborty, Supinya Iamsawat, Shikhar Mehrotra, Andrew S. Kraft, Anusara Daenthanasanmak, Elizabeth G. Hill, Carsten Krieg, Craig Beeson, Xue-Zhong Yu, Jeffrey C. Rathmell, Melissa M. Wolf, Meenal Mehrotra, Shilpak Chatterjee, Libia A. Luevano, Gabriela Andrejeva, Uday K Baliga
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(3)
Purpose: Adoptive T-cell therapy (ACT) of cancer, which involves the infusion of ex vivo–engineered tumor epitope reactive autologous T cells into the tumor-bearing host, is a potential treatment modality for cancer. However, the durable antitumor
Autor:
Keith L. Kirkwood, Ying Xiong, Meenal Mehrotra, Uday K Baliga, Makio Ogawa, In-Hong Kang, Katie R. Wilson, Beneta Parthiban, Shikhar Mehrotra, Amanda C. LaRue, Krishnamurthy Thyagarajan, Shilpak Chatterjee, James L. Borke, Emily L. Moore
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
While earlier studies have suggested that cells positive for hematopoietic markers can be found in dental tissues, it has yet to be confirmed. To conclusively demonstrate this, we utilized a unique transgenic model in which all hematopoietic cells ar
Autor:
Besim Ogretmen, Shikhar Mehrotra, Rose N. Ngang, Hung Nguyen, Gyda C. Beeson, Paramita Chakraborty, Silvia G. Vaena, Uday K Baliga, Beichu Guo, Meenal Mehrotra, Shahid Husain, Michael J. Zilliox, Krishnamurthy Thyagarajan, Shanmugam Panneer Selvam, In-Hong Kang, Zachariah Hedley, Chrystal M. Paulos, Amir A. Al-Khami, Craig Beeson, Xue-Zhong Yu, Elizabeth G. Hill, Megan W. Wyatt, Shilpak Chatterjee
Publikováno v:
Cell reports
Cell Reports, Vol 28, Iss 7, Pp 1879-1893.e7 (2019)
Cell Reports, Vol 28, Iss 7, Pp 1879-1893.e7 (2019)
SUMMARY Sphingosine 1-phosphate (S1P), a bioactive lysophospholipid generated by sphingosine kinase 1 (SphK1), regulates lymphocyte egress into circulation via S1P receptor 1 (S1PR1) signaling, and it controls the differentiation of regulatory T cell